A
Artio Medical
Formerly Metactive Medical. Develops endovascular medical devices for the embolization of vessels, aneurysms, and other vascular structures
About Artio Medical
Artio Medical, Inc., operating from its base in Prairie Village, Kansas, is a medical device company concentrated on the development of novel endovascular products. The firm was established in 2013 under the name Metactive Medical, a venture that originated from technology developed at Texas A&M University. A significant milestone was achieved in 2017 when the company rebranded to Artio Medical. The company is spearheaded by founder and CEO F. Nicholas Franano, MD, a seasoned entrepreneur in the life sciences sector with previous experience founding and leading other successful biotech and medical device companies.
The company's strategic focus is on addressing unmet needs within the peripheral vascular, neurovascular, and structural heart markets. Artio Medical's business model revolves around the design, development, and commercialization of these specialized devices, targeting hospitals and interventional specialists as its primary client base. Revenue generation is anticipated through the sale of its medical devices upon regulatory approval and market launch.
Artio's product pipeline features several key technologies. The Solus Gold Embolization Device, which received FDA 510(k) clearance in 2019, is designed for peripheral vascular occlusion. Its flexible, non-porous, balloon-like design allows for immediate and permanent vessel blockage, intended to simplify procedures and improve patient outcomes. Another key product is the Amplifi Vein Dilation System, a super-elastic nitinol device that aims to prepare veins for arteriovenous fistula creation in hemodialysis patients, a market with a significant clinical need. The company is also advancing its Comaneci and Endura Aneurysm Net products for the treatment of cerebral aneurysms, showcasing a broad approach to endovascular therapies.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 11
- Open positions
- None listed
- Dealroom signal
- 65.1/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotechnology, Neurology, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
- Investment activity
- 1 company, latest Jul 2020
- Capital deployed
- —
- Preferred round
- ACQUISITION
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Jun 2022 | $28M | $112M | Undisclosed | ↗ |
| SERIES AOther financing | Apr 2021 | $12M | $48M | Nathaniel Hagedorn · Sarah Hagedorn | — |
Growth signals
Latest recorded traffic for Artio Medical is 620 monthly website visits. Artio Medical's team declined 15.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Artio Medical in the Prairie Village ecosystem
The Artio Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
National Institutes of Health
Series A6 investors entered at this stage
Kansas Bioscience Authority
Serra Ventures- AAAll investments through Mid-America Angels:
Activate Venture Partners
Nathaniel Hagedorn
Sarah Hagedorn
Series B and later1 investor entered at this stage
- NTNovita Therapeutics
Other known investors1 additional known investor
Texas A&M University
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Artio Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Artio Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









